Trial Details

Recruiting
Basic Information
Clinical ID c2230
Identifier DRKS00030960
Trial Title Metabolic Profiling of Inflammatory Bowel Disease in Children and Adolescents - MetabIBD
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions K50 K51 K52;Crohn disease [regional enteritis];Ulcerative colitis;Other noninfective gastroenteritis and colitis
Interventions Group 1: Pediatric IBD patients receiving Infliximab - Observational group, longitudinal measurement of the metabolome in different biofluids. Group 2: Pediatric IBD patients receiving Adalimumab - Observational group, longitudinal measurement of the metabolome in different biofluids. Group 3: Pediatric patients with newly diagnosed IBD - Observational group, longitudinal measurement of the metabolome in different biofluids. Group 4: Pediatric IBD patients receiving remission induction (again) - Observational group, longitudinal measurement of the metabolome in different biofluids.
Participant Information
Sponsor Universitsklinikum Heidelberg, Klinik f Kinderheilkunde I
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -